First US Approved Stem Cell Clinical Trial for ALS

stem cells 300x168 First US Approved Stem Cell Clinical Trial for ALSALS or Lou Gehrig’s disease is a devastating disease that affects the neuromuscular system resulting in muscle weakness with eventual difficulty swallowing and breathing. For patients suffering with this condition many of the trreatments are palliative to improve function like rehabilitation. Some of my patients in the recent past have seeked stem cell based therapies in foreign countries like Costa Rica. One patient received Bone Marrow Stem Cells along with Menstural cells which were injected into his spine. These patients termed “pioneer patients” are driving change & are increasing awareness by describing their experiences. Unfortunately his treatment was not successful.  However perhaps it won’t be long before Americans won’t have to travel abroad for these procedures.

According to CNNthe first US FDA approved trial (Neuralstem) utilizing 8 week fetal tissue for stem cells is taking place. The researchers are very noble in their efforts & the patients are very brave.  However these patients have little options to reverse the effects of their disease.

Tags: , , , , , , ,

avatar

Steven Sampson D.O.

Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

Leave a Reply